As per our analysis report, the global Digital PCR and qPCR Market size is expected to grow at a rate of 8.96% and worth USD 6.12 billion by 2026.
Polymerase Chain Reaction (PCR) is an analytical process extensively used in molecular biology to make multiple copies of DNA segments. PCR can generate millions of copies from one DNA segment.
MARKET DRIVERS:
The increasing adoption rate of real-time PCR and digital PCR for diagnosing genetic disorders and other infectious diseases such as tuberculosis, malaria, and others, is a major contributing factor for the global digital PCR and qPCR market growth.
Increasing the focus of government and private organizations to develop novel and innovative digital PCR and qPCR products boosts the growth of the global market. The emergence of innovative and advanced genomic analysis products worldwide is another major factor that is fueling up the growth rate of the digital PCR and qPCR market. Digital PCR and qPCR devices are highly efficient for estimating disease-causing microbes and diagnostics analysis, which is fueling the growth of the global digital PCR and qPCR market.
Increasing expenditure of healthcare and emerging economies of the countries like U.S., China, Canada, India, U.K, Japan, and other developed and developing countries across the world owing to rise in the incidence of genetic disorders and other chronic diseases such as cancer and technological advancements are anticipated to create lucrative opportunities for the market players in the region during the forecast period. Benefits offered by digital PCR over traditional PCR such as accuracy, better sensitivity, enhanced flexibility are supposed to expand growth opportunities for the global digital PCR and qPCR market during the forecast period. Increasing applications of the qPCR consumables and reagents and other clinical applications are further assumed to offer growth opportunities for the growth of this market.
In recent years, the increasing demand for fast diagnostics, decrepit population, infectious and genetic disorders such as cancer, HIV, Hepatitis are some of the pushing factors for the global digital PCR and qPCR Market growth. Rapid technological advancements have recently attracted investments in the market are expected to offer significant changes to the global digital PCR and qPCR market during the forecast period.
MARKET RESTRAINTS:
However, technical glitches and the high initial cost of the dPCR & qPCR are a pulling force for the market. Another primary factor that is limiting the growth of the global digital PCR and qPCR market is the high costs associated with the instruments, need for capital investments on a large scale to develop advanced devices. Technical limitations related to PCR also control the adoption rate, which is another major factor challenging the growth of the global digital PCR and qPCR market.
Impact of COVID-19 on the global digital PCR and qPCR market:
COVID-19 is a global public health emergency unlike any other, affecting almost every industry. But COVID-19's sudden outbreak has driven some healthcare firms to find a solution for deadly and harmful diseases. The PCR industry has been positively impacted due to the virus and is forecasted to hit new growth heights shortly. Polymerase chain reaction (PCR) technology is used in various applications, including DNA cloning, genetic disease identification, functional gene analysis, infectious disease detection, and forensic sciences. The use of digital PCR and real-time PCR in diagnostic and drug development has seen an increase in demand in the recent past. Digital PCR is most commonly used to distinguish allele expression, monitor viral infection to individual bacterial cells, and detect fetal DNA in the bloodstream. To detect COVID-19, industry players are concentrating on developing droplet digital PCR kit tests. Regulatory agencies have also shown interest in approving these experiments to combat the COVID-19 pandemic's consequences. Several businesses have altered their business models to deal with the pandemic. As a result, the company increased its emphasis on research and development to improve COVID-19 droplet digital PCR kits, which aided in revenue growth. Thermo Fisher developed multiplex PCR kits and assays for diagnostics and testing applications to tackle the COVID-19 outbreak. The company obtained an emergency use authorization from the U.S. Food and Drug Administration for its SARSCoV2 multiplex real-time PCR test, and in 2020, it introduced AcroMetrix Coronavirus 2019 RNA Control. By considering all these factors, the global digital PCR and the qPCR market have positive growth due to the impact of COVID-19.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2020 to 2026 |
|
Base Year |
2020 |
|
Forecast Period |
2021 to 2026 |
|
Segments Covered |
By Product, Technology, Application, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
This research report on the global digital PCR and QPCR market has been segmented and sub-segmented based on the product, technology, application, end-user, and region.
Digital PCR and qPCR Market – By Product:
Based on product, the consumables and reagents segment is dominating the global market and is contributing the largest share of the global digital PCR and qPCR market and is expected to continue the trend during the forecast period owing to factors such as increased applications of qPCR reagents such assay kits and master mixes, and increasing investments from private and public organizations.
Digital PCR and qPCR Market – By Technology:
Based on the technology, the quantitative PCR segment is expected to account for the largest share during the forecast period due to the rising focus on enhancements of Point of care (POC) platforms, the ongoing stipulation in areas like genetic variation analysis, and gene expression analysis and genotyping.
Digital PCR is a next-generation testing process that assists inaccurate quantification of nucleic acids. These systems provide better sensitivity and precision related to other PCR strategies based are likely to strengthen the growth during the forecast period.
Digital PCR and qPCR Market – By Application:
Based on the application, the research and forensics segment is projected to lead the global digital PCR and qPCR market due to increased government and other private organizations for the research and the funds and investments offered by them.
The blood testing segment is also anticipated to perform well during the forecast period in the global digital PCR and qPCR market. Increasing the utilization of qPCR in disease diagnosis and the swelling of infectious diseases and genetic diseases and mounting public attention on early and efficient disease diagnosis and treatment makes this segment grow higher.
Digital PCR and qPCR Market – By End User:
Based on end-user, the hospitals and diagnostic labs segment is forecasted to contribute a significant share to the global digital PCR and qPCR market. They are foreseen to be snowballing at a high pace during the forecast period.
Digital PCR and qPCR Market – By Region:
Geographically, the North American market led the global market in 2020, followed by Europe and the Asia Pacific due to technological developments and private sector investments in these regions. The North American market is mainly driven by the factors such as growth in funds from public and private organizations for upgrading qPCR and dPCR technology, increasing cancer patient's count, and an ongoing cutback in the average price of gene sequencing.
Europe is next to North America in governing the dPCR and qPCR market globally over the estimated period. An extensive range of applications of qPCR and dPCR technologies utilized in areas like human genetic testing and forensic sciences are some factors stimulating the market growth in the region.
The digital PCR and qPCR market in Asia-Pacific are prepared to grow at a prominent CAGR during the forecast period. An increase in patient count due to the rise in chronic and infectious diseases integrated with growing alertness amid patients regarding early diagnosis of the disorders is projected to boost the market growth globally. India is projected as one of the capable markets in dPCR and qPCR, especially for the everyday importance of cancer and cardiovascular diseases in the country. According to the International Agency for Research on Cancer, the country has reported 1.2 million cancer cases in 2018, which is the primary cause of death rates in the country.
Latin America is projected to have a steady growth rate during the forecast period. Y-O-Y growth in the aging population, the presence of a considerable number of key players in the region, and growing R&D applications. The Brazilian market is predicted to lead the Latin American market during the forecast period due to the growing demand for quick diagnostics and quickly advanced technologies.
The dPCR and qPCR market of the Middle East & Africa region is anticipated to have minimal share during the forecast period. Rapid technological advancements like the development of high performance are bolstering the market growth in the region.
KEY MARKET PARTICIPANTS:
Some of the notable companies dominating the Global Digital PCR and qPCR Market profiled in this report are Thermo Fisher Scientific Inc., F Hoffman-La Roche Ltd., Bio-Rad Laboratories, Qiagen N.V., Taraka Bio Inc., Affymetrix Inc., Agilent Technologies Inc., Fluidigm Corporation, Danaher Corporation, and Becton & Dickson Company.
HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.1 Consumables & Reagents
5..3 Instruments
5.1.4 Y-o-Y Growth Analysis, BY Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Produt
5.2 Technology
5.2.1 Introduction
5.2.2 Quantitative PCR
5.2.3 Digital PCR
5.2.3 Y-o-Y Growth Analysis, By Technology
5.2.4 Market Attractiveness Analysis, By Technology
5.2.5 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Tumor
5.3.2 Blood Testing
5.3.3 Pathogen Detection
5.3.4 Research & Forensic
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Research & Forensic centers
5.4.4 Pharmaceutical & Biotechnological centers
5.4.5 Academic Centers
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Technology
6.1.5.4 By Application
6.1.5.5 By End User
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Thermo Fisher Scientific Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 F Hoffman -La Roche Inc.
8.3 Bio-Rad Laboratories
8.4 Qiagen N.V.
8.5 Taraka Bio Inc.
8.6 Affymetrix Inc.
8.7 Agilent Technologies Inc.
8.8 Fluidigm Corporation
8.9 Danaher Corporation
8.10 Bector & Dickson Company
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
